CCL2 can also recruit various immune cells (such as myeloid‐derived suppressor cells, MDSCs) to form an immunosuppressive microenvironment, which allows tumour cell to evade the body's immune surveillance and supports tumour cell proliferation.61, 62. Here, CCL2 is linked to neoplasm.